16800 West Twelve Mile Road
Suite 201, Southfield, MI 48076

Spinning Globe

DNA Design

News

Therapeutic Discovery Tax Grants Awarded

HPRL Awarded Qualifying Therapeutic Discovery Tax Grants for two of its on-going research programs; “Novel Inhibitors for the Treatment of Highly Drug-Resistant Chronic Myelogenous Leukemia” and “Discovery and Development of Anti-Diabetic Drugs.”

2009 Lasker Award

Dr. Charles Sawyers shares the 2009 Lasker Award for his work elucidating the mechanism of drug-resistance in Chronic Myelogenous Leukemia (CML).

Awarded SBIR Phase I Grant

HPRL Awarded Phase I Small Business Innovation Research (SBIR) Grant for “Novel Inhibitors for the Treatment of Highly Drug-Resistant Chronic Myelogenous Leukemia (CML).”

Awarded SBIR Phase II Grant

HPRL Awarded Phase II Small Business Innovation Research (SBIR) Grant for the “Discovery and Development of Anti-Diabetic Drugs.”